A genomics perspective of personalized prevention and management of obesity

Kalliopi K. Gkouskou,Maria G. Grammatikopoulou,Evgenia Lazou,Theodora Vasilogiannakopoulou,Despina Sanoudou,Aristides G. Eliopoulos

DOI: https://doi.org/10.1186/s40246-024-00570-3

2024-01-31

Human Genomics

Abstract:This review discusses the landscape of personalized prevention and management of obesity from a nutrigenetics perspective. Focusing on macronutrient tailoring, we discuss the impact of genetic variation on responses to carbohydrate, lipid, protein, and fiber consumption. Our bioinformatic analysis of genomic variants guiding macronutrient intake revealed enrichment of pathways associated with circadian rhythm, melatonin metabolism, cholesterol and lipoprotein remodeling and PPAR signaling as potential targets of macronutrients for the management of obesity in relevant genetic backgrounds. Notably, our data-based in silico predictions suggest the potential of repurposing the SYK inhibitor fostamatinib for obesity treatment in relevant genetic profiles. In addition to dietary considerations, we address genetic variations guiding lifestyle changes in weight management, including exercise and chrononutrition. Finally, we emphasize the need for a refined understanding and expanded research into the complex genetic landscape underlying obesity and its management.

genetics & heredity

What problem does this paper attempt to address?

This paper mainly discusses the genetic perspective of personalized prevention and management of obesity, particularly from the perspective of nutritional genetics. The research focuses on how to customize the intake of macronutrients (carbohydrates, lipids, proteins, and fiber) based on individual genetic variations to address obesity. Through bioinformatics analysis, the authors found that genetic variations related to obesity management are enriched in circadian rhythm, melatonin metabolism, cholesterol and lipoprotein remodeling, and peroxisome proliferator-activated receptors (PPAR) signaling pathways. The paper also proposes a possible drug repurposing strategy, namely the use of SYK inhibitors like fostamatinib, to treat obesity with relevant genetic backgrounds.

In addition, the paper discusses how genetic variations can guide lifestyle changes such as exercise and chrono-nutrition in weight management. It emphasizes the need for a deeper understanding of the complex genetic background of obesity and expands related research. Through studies on genetic risk scores (GRS) and polygenic risk scores (PRS), the paper highlights that these tools can be used for susceptibility assessment of obesity and that different macronutrients may have varying efficiencies in weight management.

The paper points out the limitations of current "one-size-fits-all" nutrition and lifestyle strategies in addressing obesity and advocates for precision nutrition management based on individual genetic differences. It investigates the genetic differences in the impact of carbohydrate, lipid, and protein intake as well as fiber on weight and proposes the association between fiber intake and metabolic health as well as the reduction of obesity-related disease risks.

In summary, this paper attempts to address how to achieve personalized prevention and management of obesity through genetic information, particularly in terms of nutritional intervention and lifestyle changes.